小程序掃碼下單
本網(wǎng)站銷(xiāo)售的所有產(chǎn)品僅用于工業(yè)應(yīng)用或者科學(xué)研究等非醫(yī)療目的，不可用于人類(lèi)或動(dòng)物的臨床診斷或者治療，非藥用，非食用。
Recombinant Human B7-H2/ICOSLG, Fc Chimera (HEK293-expressed)
英文名：
Cas號(hào)：
Cas號(hào)：
檢測(cè)信息查詢
| 貨號(hào) | 規(guī)格 | 貨期 | 庫(kù)存 | 價(jià)格 | 促銷(xiāo)價(jià) | 訂購(gòu) |
| 1308132835-10 μg | 0 | ￥2200 | ||||
| 1308132835-50 μg | 0 | ￥4200 |
| 別 名 | |
| Cas號(hào) | |
| M D L | |
| 分子式 | |
| 分子量 | |
| 產(chǎn)品參數(shù) | |
| 性狀 | Recombinant Human B7-H2/ICOSLG, Fc Chimera (HEK293-expressed) 是 HEK293 細(xì)胞中產(chǎn)生的 C-末端含人 IgG1 Fc 片段的多肽鏈。ICOSLG 屬于共刺激分子 B7 家族。
Synonyms rHuB7-H2/ICOSLG, Fc Chimera; B7 homolog 2; B7RP-1; CD275 Species Human Source HEK 293 Accession O75144 Gene ID 23308 Molecular Weight 70-80 kDa AA Sequence DTQEKEVRAM VGSDVELSCA CPEGSRFDLN DVYVYWQTSE SKTVVTYHIP QNSSLENVDS RYRNRALMSP AGMLRGDFSL RLFNVTPQDE QKFHCLVLSQ SLGFQEVLSV EVTLHVAANF SVPVVSAPHS PSQDELTFTC TSINGYPRPN VYWINKTDNS LLDQALQNDT VFLNMRGLYD VVSVLRIART PSVNIGCCIE NVLLQQNLTV GSQTGNDIGE RDKITENPVS TGEKNAATWS Biological Activity 5 μg/mL (100 μL/well) of immoblized recombinant human B7-H2/ICOSLG-Fc can bind human Biotin-B7-H2/ICOSLG-Fc with a linear range of 0.76-12.21 μg/mL. Appearance Lyophilized powder. Formulation Lyophilized after extensive dialysis against PBS, 5% trehalose and mannitol. Endotoxin Level <0.2 EU/μg, determined by LAL method. Reconstitution Reconstitute the lyophilized recombinant Human B7-H2/ICOSLG, Fc Chimera (HEK293-expressed) (rHuB7-H2/ICOSLG, Fc Chimera) to 100 μg/mL using ddH2O or diluted with PBS. Storage & Stability Lyophilized recombinant Human B7-H2/ICOSLG, Fc Chimera (HEK293-expressed) (rHuB7-H2/ICOSLG, Fc Chimera) is stored at -20°C. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer. It is recommended to freeze aliquots at -20°C or -80°C for extended storage. Shipping Room temperature in continental US; may vary elsewhere. Background As a member of the B7 family, inducible co-stimulator ligand (ICOSLG) expressed on tumor cell has been reported to have an important role in tumor immunity. As the counter ligand of ICOS, a CD28-related molecule, ICOSLG is expressed on professional antigen-presenting cell (APCs; such as dendritic cells (DCs) and B cells) and on some tumor cells (such as glioma cells and gastric carcinoma cells). ICOSLG is the only B7 family member that preferentially co-stimulates type 2T helper cell (Th2) responses, and interestingly, this unique molecule has a critical role in antitumor immunity. ICOSLG expression on solid tumors (implanted-transfected tumors) aids in both NK mediated and CD8+ cytotoxic T cell (CTL) activation and killing. Several studies using ICOSLG-transfected solid tumor cell lines found that ICOSLG induced CD8+ cytotoxic lymphocyte-mediated tumor regression[1]. |
| 貯存 |
- Recombinant Mouse April/TNFSF13
- Recombinant Human B7-1/CD80, Fc Chimera (HEK293-expressed)
- Recombinant Human B7-2/CD86, Fc Chimera (HEK293-expressed)
- Recombinant Human B7-2/CD86, Fc-His (HEK293-expressed)
- Recombinant Human B7-H2/ICOSLG, Fc Chimera (HEK293-expressed)
- Recombinant Human B7-H2/ICOSLG, His (HEK293-expressed)
- Recombinant Human B7-H3/ICOSLG, Fc Chimera (HEK293-expressed)
- Recombinant Human B7-H3/ICOSLG, His (HEK293-expressed)
- PVP包覆的銀納米線
滬公網(wǎng)安備 31012002003054號(hào)